3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
enzalutamide
2
ostarine
1
nilutamide
1
exemestane
1
bicalutamide
1
apalutamide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Bulbo-Spinal Atrophy, X-Linked
×
nilutamide
×
Clear all
NCT00918385
2014-10-29
ARS
Duke University
Phase 2
Terminated
57 enrolled
8 charts